From catastrophizing to catalyzing: does pain catastrophizing modulate the beneficial impact of open-label placebos for chronic low back pain? A secondary analysis
Chronic back pain (CBP) is a global health problem with significant health and economic consequences. Traditional analgesics are often no better than placebo, highlighting the need for biopsychosocial approaches. Open-label placebos (OLPs), administered with patient consent, offer a promising altern...
Saved in:
| Main Authors: | Elif Buse Caliskan, Katharina Schmidt, Andreas Hellmann, Tamás Spisák, Ulrike Bingel, Julian Kleine-Borgmann |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Psychology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fpsyg.2025.1522634/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Catastrophization, pain and disability in patients with chronic low back pain
by: Mirjana Berković-Šubić, et al.
Published: (2025-06-01) -
Placebo and the law of identification
by: Steve F. Bierman, et al.
Published: (2024-12-01) -
The Two Sides of Placebo Analgesia: Differential Functional Connectivity Reveals Mechanisms of Placebo Analgesic Response
by: Bush NJ, et al.
Published: (2025-01-01) -
The ethics of placebos
by: Donna Knapp van Bogaert, et al.
Published: (2013-02-01) -
Historical milestones of the invention and use of placebo
by: A. N. Koterov
Published: (2023-01-01)